The US Food and Drug Administration took another action against Ranbaxy Laboratories Ltd on Thursday prohibiting it from making or selling drug ingredients from its Toansa India plant for the US market Ranbaxy an Indian unit of Japans Daiichi Sankyo Co has been a major supplier of drug ingredients to the USespecially for generic drugsbut has come under FDA scrutiny of late The
  